Blog

MilliporeSigma Brings Customers Closer to Gene Therapy Product Commercialization – PR Newswire (press release)


PR Newswire (press release)

MilliporeSigma Brings Customers Closer to Gene Therapy Product Commercialization
PR Newswire (press release)
BURLINGTON, Mass., Oct. 19, 2017 /PRNewswire/ — MilliporeSigma today announced that its Carlsbad, California-based manufacturing facility for the production of BioReliance® viral and gene therapy products has completed both a U.S. Food & Drug …

and more »

2017-10-19 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.